Combined utility of p16 and BRAF V600E in the evaluation of spitzoid tumors: Superiority to PRAME and correlation with FISH.

MLA

McAfee, John L., et al. “Combined Utility of P16 and BRAF V600E in the Evaluation of Spitzoid Tumors: Superiority to PRAME and Correlation with FISH.” Journal of Cutaneous Pathology, vol. 50, no. 2, Feb. 2023, pp. 155–68. EBSCOhost, https://doi.org/10.1111/cup.14342.

APA

McAfee, J. L., Scarborough, R., Jia, X. S., Azzato, E. M., Astbury, C., Ronen, S., Andea, A. A., Billings, S. D., & Ko, J. S. (2023). Combined utility of p16 and BRAF V600E in the evaluation of spitzoid tumors: Superiority to PRAME and correlation with FISH. Journal of Cutaneous Pathology, 50(2), 155–168. https://doi.org/10.1111/cup.14342

Chicago

McAfee, John L., Richard Scarborough, Xuefei Sophia Jia, Elizabeth M. Azzato, Caroline Astbury, Shira Ronen, Aleodor A. Andea, Steven D. Billings, and Jennifer S. Ko. 2023. “Combined Utility of P16 and BRAF V600E in the Evaluation of Spitzoid Tumors: Superiority to PRAME and Correlation with FISH.” Journal of Cutaneous Pathology 50 (2): 155–68. doi:10.1111/cup.14342.